ALUR 📈 Allurion Technologies - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock •
ALUR: Balloon, Monitoring, Messaging, Telehealth, Virtual Care
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts. Web URL: https://www.allurion.com
Additional Sources for ALUR Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ALUR Stock Overview
| Market Cap in USD | 20m |
| Sector | Healthcare |
| Industry | Medical Devices |
| GiC Sub-Industry | Specialized Consumer Services |
| IPO / Inception | 2023-08-02 |
ALUR Stock Ratings
| Growth 5y | -83.6% |
| Fundamental | -14.7% |
| Dividend | - |
| Rel. Strength Industry | -435 |
| Analysts | 4.25/5 |
| Fair Price Momentum | 2.21 USD |
| Fair Price DCF | - |
ALUR Dividends
No Dividends PaidALUR Growth Ratios
| Growth Correlation 3m | -80.2% |
| Growth Correlation 12m | -95.7% |
| Growth Correlation 5y | -56.8% |
| CAGR 5y | -68.69% |
| CAGR/Mean DD 5y | -2.22 |
| Sharpe Ratio 12m | -0.92 |
| Alpha | -114.98 |
| Beta | 0.72 |
| Volatility | 171.40% |
| Current Volume | 189.3k |
| Average Volume 20d | 56.8k |
What is the price of ALUR stocks?
As of January 14, 2025, the stock is trading at USD 2.97 with a total of 189,326 shares traded.
Over the past week, the price has changed by -66.52%, over one month by -65.66%, over three months by -82.56% and over the past year by -96.60%.
As of January 14, 2025, the stock is trading at USD 2.97 with a total of 189,326 shares traded.
Over the past week, the price has changed by -66.52%, over one month by -65.66%, over three months by -82.56% and over the past year by -96.60%.
Is Allurion Technologies a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Allurion Technologies is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -14.66 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALUR as of January 2025 is 2.21. This means that ALUR is currently overvalued and has a potential downside of -25.59%.
Neither. Based on ValueRay Fundamental Analyses, Allurion Technologies is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -14.66 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALUR as of January 2025 is 2.21. This means that ALUR is currently overvalued and has a potential downside of -25.59%.
Is ALUR a buy, sell or hold?
Allurion Technologies has received a consensus analysts rating of 4.25. Therefor, it is recommend to buy ALUR.
Allurion Technologies has received a consensus analysts rating of 4.25. Therefor, it is recommend to buy ALUR.
- Strong Buy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for ALUR stock price target?
According to ValueRays Forecast Model, ALUR Allurion Technologies will be worth about 2.4 in January 2026. The stock is currently trading at 2.97. This means that the stock has a potential downside of -19.87%.
According to ValueRays Forecast Model, ALUR Allurion Technologies will be worth about 2.4 in January 2026. The stock is currently trading at 2.97. This means that the stock has a potential downside of -19.87%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 34.5 | 1061.6% |
| Analysts Target Price | 45.8 | 1443.1% |
| ValueRay Target Price | 2.4 | -19.9% |